TY - JOUR
T1 - Effect of psyllium in hypercholesterolemia at two monounsaturated fatty acid intakes
AU - Jenkins, David J.A.
AU - Wolever, Thomas M.S.
AU - Vidgen, Edward
AU - Kendall, Cyril W.C.
AU - Ransom, Thomas P.P.
AU - Mehling, Christine C.
AU - Mueller, Sharon
AU - Cunnane, Stephen C.
AU - O'Connell, Nancy C.
AU - Setchell, Kenneth D.R.
AU - Lau, Herbert
AU - Teitel, Jerome M.
AU - Garvey, M. Bernadette
AU - Fulgoni, Victor
AU - Connelly, Philip W.
AU - Patten, Robert
AU - Corey, Paul N.
PY - 1997/5
Y1 - 1997/5
N2 - We performed two studies to determine whether the lipid-lowering effect of viscous soluble fiber was modified by monounsaturated fatty acid (MUFA). First, psyllium (1.4 g/MJ) was compared with wheat bran (control) in 1-mo metabolic diets by using a randomized crossover design (n = 32 hyperlipidemic subjects). The background diet contained ≃6% of energy as MUFA (20% of total fat). The second study (n = 27 hyperlipidemic subjects) was similar to the first but the background diet contained ≃12% MUFA (29% of total fat) because of the addition of canola oil. At both fat intakes, psyllium resulted in significant reductions in total, low-density-lipoprotein (LDL), and high- density-lipoprotein (HDL) cholesterol compared with the wheat bran control. For the psyllium diet at 6% compared with 12% MUFA, the decreases in LDL cholesterol were 12.3 ± 1.5% (P < 0.001) and 15.3 ± 2.4% (P < 0.001), respectively. With the higher-MUFA diet triacylglycerol fell significantly over the control phase (16.6 ± 5.5%, P = 0.006) and the ratio of LDL to HDL cholesterol fell significantly over the psyllium phase (7.3 ± 2.8%, P = 0.015). Psyllium and MUFA intakes were negatively related to the percentage change in the ratio of LDL to HDL cholesterol (r = -0.34. P = 0.019 and r = - 0.44, P = 0.002, respectively). Chenodeoxycholate synthesis rate increased (30 ± 13%, P = 0.038) with the psyllium diet in the 12 subjects in whom this was assessed. We conclude that psyllium lowered LDL- and HDL-cholesterol concentrations similarly at both MUFA intakes. However, there may some advantage in combining soluble fiber and MUFA to reduce the ratio of LDL to HDL cholesterol.
AB - We performed two studies to determine whether the lipid-lowering effect of viscous soluble fiber was modified by monounsaturated fatty acid (MUFA). First, psyllium (1.4 g/MJ) was compared with wheat bran (control) in 1-mo metabolic diets by using a randomized crossover design (n = 32 hyperlipidemic subjects). The background diet contained ≃6% of energy as MUFA (20% of total fat). The second study (n = 27 hyperlipidemic subjects) was similar to the first but the background diet contained ≃12% MUFA (29% of total fat) because of the addition of canola oil. At both fat intakes, psyllium resulted in significant reductions in total, low-density-lipoprotein (LDL), and high- density-lipoprotein (HDL) cholesterol compared with the wheat bran control. For the psyllium diet at 6% compared with 12% MUFA, the decreases in LDL cholesterol were 12.3 ± 1.5% (P < 0.001) and 15.3 ± 2.4% (P < 0.001), respectively. With the higher-MUFA diet triacylglycerol fell significantly over the control phase (16.6 ± 5.5%, P = 0.006) and the ratio of LDL to HDL cholesterol fell significantly over the psyllium phase (7.3 ± 2.8%, P = 0.015). Psyllium and MUFA intakes were negatively related to the percentage change in the ratio of LDL to HDL cholesterol (r = -0.34. P = 0.019 and r = - 0.44, P = 0.002, respectively). Chenodeoxycholate synthesis rate increased (30 ± 13%, P = 0.038) with the psyllium diet in the 12 subjects in whom this was assessed. We conclude that psyllium lowered LDL- and HDL-cholesterol concentrations similarly at both MUFA intakes. However, there may some advantage in combining soluble fiber and MUFA to reduce the ratio of LDL to HDL cholesterol.
UR - http://www.scopus.com/inward/record.url?scp=0030936424&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030936424&partnerID=8YFLogxK
U2 - 10.1093/ajcn/65.5.1524
DO - 10.1093/ajcn/65.5.1524
M3 - Article
C2 - 9129487
AN - SCOPUS:0030936424
SN - 0002-9165
VL - 65
SP - 1524
EP - 1533
JO - American Journal of Clinical Nutrition
JF - American Journal of Clinical Nutrition
IS - 5
ER -